4
Changes in Ownership
Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-23-025330
Options or other derivatives
- Director acquired 130,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| DELUCCIA ROBERT J Director | 2023-02-13 | Grant or award · Stock Option | +130,000 | 130,000 | D | ||
Loading xslF345X03/tm237745-1_4seq1.xml…